13.07.2014 Views

NCCR Guide 2013 - Schweizerischer Nationalfonds (SNF)

NCCR Guide 2013 - Schweizerischer Nationalfonds (SNF)

NCCR Guide 2013 - Schweizerischer Nationalfonds (SNF)

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Statistical Input – Output Data<br />

Funding source (CHF) Year 9 Year 10 Year 11 Year 12 Total %<br />

SNSF funding 3 600 000 2 000 000 1 500 000 800 000 7 900 000 21<br />

Self-funding from home<br />

institution 1 1 226 033 1 851 950 1 315 865 1 495 865 5 889 713 16<br />

Self-funding from ETH<br />

Zurich<br />

577 679 730 227 703 600 703 600 2 715 106 7<br />

Self-funding from project<br />

participants<br />

6 537 153 6 663 000 6 277 035 703 600 20 180 788 55<br />

Third-party funding 2 10 552 6 323 47 405 18 100 82 380 0<br />

Total 11 951 417 11 251 500 9 843 905 3 721 165 36 767 987 100<br />

Personnel 3<br />

1<br />

Personnel costs, equipment and consumables, not included infrastructure and basic equipment<br />

2<br />

Not included is CTI funding. Since the start of the <strong>NCCR</strong> 2 projects have been funded by CTI at a total amount<br />

of 2.1 million CHF (cf. third table).<br />

3<br />

Persons involved in the <strong>NCCR</strong> in the last reporting period (12 months)<br />

4<br />

Full-time equivalent, including <strong>NCCR</strong>-Director and persons in charge of knowledge and technology transfer,<br />

and education and training<br />

5<br />

Including leaders of the individual projects and other organisational units of the <strong>NCCR</strong><br />

6<br />

This table displays the major indicators in knowledge and technology transfer; other data is available as well (see text on<br />

“achievements”). The output data of <strong>NCCR</strong>s differ considerably according to disciplinary cultures.<br />

7<br />

Start-up companies that have been built up or were considerably supported by <strong>NCCR</strong>s.<br />

8<br />

Projects funded by the Commission for Technology and Innovation (CTI) that have been initiated by members of <strong>NCCR</strong>s<br />

and are thematically linked to <strong>NCCR</strong> projects.<br />

Evaluation and Monitoring by the Swiss National Science Foundation (SNSF)<br />

Members of the Review Panel<br />

Kléber André, Prof. (Chair)<br />

Eisenberg David, Prof.<br />

Fromm Katharina, Prof.<br />

Hall Mike, Prof.<br />

Michel Hartmut, Prof.<br />

Schmid Franz Xaver, Prof.<br />

Widmer Hans, Dr.<br />

Wright Ernest M., Prof.<br />

Wright Peter E., Prof.<br />

<strong>NCCR</strong> Office SNSF<br />

Christ Urs, Dr.<br />

Total of<br />

Persons<br />

Female % Male % CH Most Represented Nations Other<br />

Nations<br />

DE FR CN PL AT<br />

Management 3.0 4 2 25 6 75 3 2 1 0 0 0 2<br />

Master students 0 0 0 0 0 0 0 0 0 0 0 0<br />

Doctoral students 49 17 35 32 65 18 16 2 2 2 1 8<br />

Postdoctoral students 34 11 32 23 68 7 14 2 2 1 0 8<br />

Research associates 0 0 0 0 0 0 0 0 0 0 0 0<br />

Senior researchers 5 36 7 19 29 81 9 8 3 1 1 3 12<br />

Other staff 21 19 90 2 10 12 3 1 0 2 0 4<br />

Total 143.00 56 38 92 62 49 43 9 5 6 4 34<br />

Type of output 6<br />

Totals<br />

Publications > 609 Peer-reviewed | 9 Not peer-reviewed | 13 Anthology articles | 25 Books | 0 Reports 656<br />

Presentations at congresses > 1561<br />

Cooperations > 4 Programmes | 222 Research institutions | 41 Private sector | 0 Other 267<br />

Transfer activities > 24 Patents | 12 Licenses | 2 Start-ups 7 | 1 Prototypes/processes | 2 CTI-projects 8 41<br />

Swiss National Science Foundation, Berne, CH<br />

UCLA-DOE Institute for Genomics and Proteomics, US<br />

Swiss National Science Foundation, Berne, CH<br />

Swiss National Science Foundation, Berne, CH<br />

Max-Planck Institut für Biophysik, Frankfurt am Main, DE<br />

Laboratorium für Biochemie, Universität Bayreuth, DE<br />

Novartis Pharma AG, Basel, CH<br />

UCLA School of Medicine, Los Angeles, US<br />

Department of Molecular Biology, The Scripps Research<br />

Institute, La Jolla, US<br />

Schweiz. <strong>Nationalfonds</strong>, Wildhainweg 3, 3001 Bern<br />

phone: + 41 (0)31 308 23 50, fax: + 41 (0)31 305 29 71, uchrist@snf.ch<br />

• Laboratoire d’Enzymologie et<br />

Biochimie Structurales, Centre<br />

national de la Recherche<br />

Scientifique, Gif-sur-Yvette, FR<br />

• Lab. für Physikalische Chemie,<br />

ETH Zurich, Zurich, CH<br />

• Laboratory of Molecular Biology,<br />

National Institutes of Health,<br />

Bethesda, US<br />

• Laboratory of Protein<br />

Phosphorylation, Katholieke<br />

Universiteit Leuven, BE<br />

• M. D. Anderson Cancer Center,<br />

University of Texas, Houston, US<br />

• Max Planck Institute of Coal<br />

Research, Mühlheim, DE<br />

• Max von Pettenkofer Institute,<br />

Ludwig-Maximilians<br />

University of Munich, DE<br />

• Medizinische Biochemie und<br />

Molekularbiologie der Universität<br />

des Saarlands, Homburg, DE<br />

• National Chemical Laboratory<br />

(NCL), Central NMR Facility,<br />

Pune, IN<br />

• National Institute of<br />

Biotechnology, Madrid, ES<br />

• Russian Academy of Sciences,<br />

Moscow, RU<br />

• San Diego Joint Center for<br />

Structural Genomics, US<br />

• School of Biological Sciences,<br />

University of Auckland, NZ<br />

• School of Chemistry and<br />

Molecular Bioscience,<br />

The University of Queensland,<br />

Brisbane, AU<br />

• School of Medicine, Stanford<br />

University, Stanford, CA, US<br />

• Structural Biology – VUB,<br />

Free University of Brussels, BE<br />

• The Scripps Research Institute,<br />

La Jolla, US<br />

• UCL Cancer Institute,<br />

University College London, GB<br />

• Zentrum für Molekulare<br />

Biologie (ZMBH),<br />

Universität Heidelberg, DE<br />

Economy / Industry<br />

• Boehringer Ingelheim Pharma<br />

GmbH & Co. KG, Biberach, DE<br />

• Bruker AXS GmbH,<br />

Karlsruhe, DE<br />

• Cambridge Antibody Technology,<br />

Cambridge, GB<br />

• F. Hoffmann-La Roche Ltd.,<br />

Basel, CH<br />

• Molecular Dimensions Limited,<br />

Newmarket, GB<br />

• Molecular Partners AG,<br />

Zurich, CH<br />

• MorphoSys AG, Martinsried, DE<br />

• Roche Deutschland Holding<br />

GmbH, Penzberg, DE<br />

• Swissci AG, Neuheim, CH<br />

<strong>Guide</strong> <strong>2013</strong> | 19

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!